Cargando…

A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease

OBJECTIVE: To determine psychometric properties of the PROMIS-10 and Standard Stroke Question Set (by International Consortium for Health Outcome Measures) presented as a new 15-item Patient Related Outcome (PRO), for patients with: acquired Brain Injury (ABI), Multiple sclerosis (MS) and Parkinson’...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Ben, Hayes, Chloe, Smith, Alexander, Pennington, Anna, Price, Michelle, Pearson, Owen, Vitoratou, Silia, Hewitt, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177510/
https://www.ncbi.nlm.nih.gov/pubmed/34086698
http://dx.doi.org/10.1371/journal.pone.0251484
_version_ 1783703394806923264
author Carter, Ben
Hayes, Chloe
Smith, Alexander
Pennington, Anna
Price, Michelle
Pearson, Owen
Vitoratou, Silia
Hewitt, Jonathan
author_facet Carter, Ben
Hayes, Chloe
Smith, Alexander
Pennington, Anna
Price, Michelle
Pearson, Owen
Vitoratou, Silia
Hewitt, Jonathan
author_sort Carter, Ben
collection PubMed
description OBJECTIVE: To determine psychometric properties of the PROMIS-10 and Standard Stroke Question Set (by International Consortium for Health Outcome Measures) presented as a new 15-item Patient Related Outcome (PRO), for patients with: acquired Brain Injury (ABI), Multiple sclerosis (MS) and Parkinson’s disease (PD). METHODS: In an eight centre, UK wide, cross-sectional study we approached patients during their routine follow-up to complete: a disease-specific instrument (European Brain Injury Questionnaire, Multiple Sclerosis Impact Scale, and Parkinson’s disease questionnaire); General Health questionnaire with a Quality of life measure (EQ-5D); and PRO. We validated the PRO using factor analysis to define the latent construct domains, then calculated the internal consistency (Cronbach’s-α), and construct validity (correlation). RESULTS: There were 340 patients with ABI (N = 91, median age = 55.1, 41% female), MS (N = 99, age = 58.9, 69%) and PD (N = 150, age = 74.5, 40%). Factor analysis suggested the PRO offered three domains of: physical health; functionality-capacity and mental health. All factors correlated strongly with the three disease-specific instruments, and the overall PRO had a large correlation with the EQ-5D (correlation>0.8) offering good construct validity and excellent internal consistency (∝>0.89). INTERPRETATION: The PRO offered promising psychometric properties and could be used in place of disease specific questionnaires for patients with ABI, MS, and PD. The PRO has three construct domains, describing patients’: mental health; physical health; and functional-capacity, and may be used in routine clinical practice. The PRO offered both relevance to each of the three separate neurological conditions and generalisability across all the conditions, increasing its utility.
format Online
Article
Text
id pubmed-8177510
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81775102021-06-07 A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease Carter, Ben Hayes, Chloe Smith, Alexander Pennington, Anna Price, Michelle Pearson, Owen Vitoratou, Silia Hewitt, Jonathan PLoS One Research Article OBJECTIVE: To determine psychometric properties of the PROMIS-10 and Standard Stroke Question Set (by International Consortium for Health Outcome Measures) presented as a new 15-item Patient Related Outcome (PRO), for patients with: acquired Brain Injury (ABI), Multiple sclerosis (MS) and Parkinson’s disease (PD). METHODS: In an eight centre, UK wide, cross-sectional study we approached patients during their routine follow-up to complete: a disease-specific instrument (European Brain Injury Questionnaire, Multiple Sclerosis Impact Scale, and Parkinson’s disease questionnaire); General Health questionnaire with a Quality of life measure (EQ-5D); and PRO. We validated the PRO using factor analysis to define the latent construct domains, then calculated the internal consistency (Cronbach’s-α), and construct validity (correlation). RESULTS: There were 340 patients with ABI (N = 91, median age = 55.1, 41% female), MS (N = 99, age = 58.9, 69%) and PD (N = 150, age = 74.5, 40%). Factor analysis suggested the PRO offered three domains of: physical health; functionality-capacity and mental health. All factors correlated strongly with the three disease-specific instruments, and the overall PRO had a large correlation with the EQ-5D (correlation>0.8) offering good construct validity and excellent internal consistency (∝>0.89). INTERPRETATION: The PRO offered promising psychometric properties and could be used in place of disease specific questionnaires for patients with ABI, MS, and PD. The PRO has three construct domains, describing patients’: mental health; physical health; and functional-capacity, and may be used in routine clinical practice. The PRO offered both relevance to each of the three separate neurological conditions and generalisability across all the conditions, increasing its utility. Public Library of Science 2021-06-04 /pmc/articles/PMC8177510/ /pubmed/34086698 http://dx.doi.org/10.1371/journal.pone.0251484 Text en © 2021 Carter et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Carter, Ben
Hayes, Chloe
Smith, Alexander
Pennington, Anna
Price, Michelle
Pearson, Owen
Vitoratou, Silia
Hewitt, Jonathan
A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease
title A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease
title_full A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease
title_fullStr A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease
title_full_unstemmed A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease
title_short A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease
title_sort single patient reported outcome measure for acquired brain injury, multiple sclerosis & parkinson’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177510/
https://www.ncbi.nlm.nih.gov/pubmed/34086698
http://dx.doi.org/10.1371/journal.pone.0251484
work_keys_str_mv AT carterben asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT hayeschloe asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT smithalexander asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT penningtonanna asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT pricemichelle asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT pearsonowen asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT vitoratousilia asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT hewittjonathan asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT carterben singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT hayeschloe singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT smithalexander singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT penningtonanna singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT pricemichelle singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT pearsonowen singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT vitoratousilia singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease
AT hewittjonathan singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease